MiR-3677-3p promotes development and sorafenib resistance of hepatitis B-related hepatocellular carcinoma by inhibiting FOXM1 ubiquitination
Hengzheng He, Jian Zhou, Fahui Cheng, Huijuan Li, Yangya Quan
Topics & Concepts
HBxHepatocellular carcinomaSorafenibCancer researchHepatitis B virusChemistryUbiquitinmicroRNABiologyVirologyVirusBiochemistryGeneFOXO transcription factor regulationAutophagy in Disease and TherapyCancer Mechanisms and Therapy